EMA advice on the use of NSAIDs for Covid-19.

Szczegóły
Abstrakt

Tytuł:: EMA advice on the use of NSAIDs for Covid-19.
Źródło:: Drug and therapeutics bulletin [Drug Ther Bull] 2020 May; Vol. 58 (5), pp. 69. Date of Electronic Publication: 2020 Mar 31.
Typ publikacji:: Journal Article
Język:: English
Imprint Name(s):: Publication: Jan. 2007- : London : BMJ Pub. Group
Original Publication: London, Consumers' Association
MeSH Terms:: Anti-Inflammatory Agents, Non-Steroidal*/adverse effects
Anti-Inflammatory Agents, Non-Steroidal*/therapeutic use
Betacoronavirus*
Coronavirus Infections/*drug therapy
Pneumonia, Viral/*drug therapy
COVID-19 ; Europe ; Humans ; Ibuprofen/adverse effects ; Ibuprofen/therapeutic use ; International Agencies ; Pandemics ; SARS-CoV-2 ; COVID-19 Drug Treatment
Contributed Indexing:: Keywords: Health Care Quality, Access, and Evaluation; Primary Health Care
Substance Nomenclature:: 0 (Anti-Inflammatory Agents, Non-Steroidal)
WK2XYI10QM (Ibuprofen)
Entry Date(s):: Date Created: 20200403 Date Completed: 20200501 Latest Revision: 20221207
Update Code:: 20240105
DOI:: 10.1136/dtb.2020.000021
PMID:: 32234728
: Czasopismo naukowe

Every month, DTB scans sources of information on treatments, disease management and other healthcare topics for key items to bring to our readers' attention and help them keep up to date. To do this, we produce succinct, contextualised summaries of the information concerned.
(© BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.)

Informacja